Evaluation of the 6-Month Effect of Sacubitril-Valsartan Compared to ACEI and ARB on LVEF in Heart Failure Patients: A Double-Blind Randomized Clinical Trial
In this study, SV was shown to be superior to ACEI and ARB in improving LVEF in heart failure patients at 6 months follow-up. These findings highlight the potential benefits of SV in the management of heart failure.
Authors
- Maryam Farhadian (ORCID: https://orcid.org/0000-0002-6054-9850)
- Nakisa Khansari (ORCID: https://orcid.org/0000-0002-6272-9492)
- Farnaz Fariba (ORCID: https://orcid.org/0000-0001-7641-2691)
- Farnosh Masmoo
Institutions
- Hamedan University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Pharmacy And Bioallied Sciences
- Published
- 2025-04-29
- DOI
- https://doi.org/10.4103/jpbs.jpbs_133_25
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00